JW Therapeutics Announces NMPA Approval of Relmacabtagene Auto...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SHANGHAI, Sept. 6, 2021/PRNewswire-AsiaNet/ -- - The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product globally - Currently the only approved CAR-T product that has been simultaneously included in the Nat...
Authors: LATEST ASIANET NEWS RELEASES